Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupropion vs Nicotine Patch for Lighter Smokers
NCT00086411Phase 2Completed
- Sponsor
- University of Pennsylvania
- Start
- Sep 2003
- Primary completion
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of bupropion in Tobacco Use Disorder (TUD) (4 arms), sponsored by University of Pennsylvania. Primary endpoint: Percent Treatment Sessions Attended at 52 weeks. Started Sep 2003; status: completed.
02
Drugs
bupropion
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT00086411.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00086411.